Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zura Bio Limited - Class A Ordinary shares
(NQ:
ZURA
)
3.210
-0.220 (-6.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,070,548
Open
3.330
Bid (Size)
3.230 (11)
Ask (Size)
3.290 (1)
Prev. Close
3.430
Today's Range
3.180 - 3.510
52wk Range
0.9700 - 5.070
Shares Outstanding
62,064,270
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Unusual volume stocks are being observed in Wednesday's session.
October 01, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Here are the top movers in Tuesday's session.
September 30, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Performance
YTD
+36.6%
+36.6%
1 Month
+63.8%
+63.8%
3 Month
+63.8%
+63.8%
6 Month
+161.0%
+161.0%
1 Year
-29.1%
-29.1%
More News
Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 30, 2025
Via
Benzinga
These stocks are moving in today's session
September 30, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
September 29, 2025
Via
Benzinga
Top stock movements in today's session.
September 29, 2025
Via
Chartmill
Wondering what's happening in today's pre-market session?
September 29, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 29, 2025
Via
Benzinga
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
September 29, 2025
Via
Benzinga
Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference
August 20, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
August 14, 2025
From
Zura Bio Limited
Via
Business Wire
Novartis Drug Shows Improvement In Sjögren's Disease In Late-Stage Trials: Analyst Deems Data Positive For Zura Bio As Well
August 11, 2025
Via
Stocktwits
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 17, 2025
From
Zura Bio
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 17, 2025
Via
Benzinga
Zura Bio Announces Chief Financial Officer Transition
July 01, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present at the Jefferies Global Healthcare Conference
May 27, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa
May 20, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates
May 08, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates
March 25, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present at the Leerink Partners Global Healthcare Conference
February 24, 2025
From
Zura Bio Limited
Via
Business Wire
Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis
December 23, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
November 14, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
November 07, 2024
From
Zura Bio Limited
Via
Business Wire
Zura Bio to Participate in Two Upcoming Investor Conferences in November
October 30, 2024
From
Zura Bio
Via
Business Wire
Frequently Asked Questions
Is Zura Bio Limited - Class A Ordinary shares publicly traded?
Yes, Zura Bio Limited - Class A Ordinary shares is publicly traded.
What exchange does Zura Bio Limited - Class A Ordinary shares trade on?
Zura Bio Limited - Class A Ordinary shares trades on the Nasdaq Stock Market
What is the ticker symbol for Zura Bio Limited - Class A Ordinary shares?
The ticker symbol for Zura Bio Limited - Class A Ordinary shares is ZURA on the Nasdaq Stock Market
What is the current price of Zura Bio Limited - Class A Ordinary shares?
The current price of Zura Bio Limited - Class A Ordinary shares is 3.210
When was Zura Bio Limited - Class A Ordinary shares last traded?
The last trade of Zura Bio Limited - Class A Ordinary shares was at 10/17/25 04:00 PM ET
What is the market capitalization of Zura Bio Limited - Class A Ordinary shares?
The market capitalization of Zura Bio Limited - Class A Ordinary shares is 199.23M
How many shares of Zura Bio Limited - Class A Ordinary shares are outstanding?
Zura Bio Limited - Class A Ordinary shares has 199M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.